MBX Biosciences, Inc. Common Stock (MBX) Stock Overview
Explore MBX Biosciences, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.
MBX Biosciences, Inc. Common Stock (MBX)
Key Financials
Key Financials
Market Cap
2.9B
P/E Ratio
-26.13
EPS (TTM)
$-2.41
ROE
-0.26%
MBX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of MBX Biosciences, Inc. Common Stock (NASDAQ: MBX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, MBX Biosciences, Inc. Common Stock's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MBX on the NASDAQ shows an RSI of 44.83, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $78.55 for the NASDAQ listing.
Key metrics behind MBX Biosciences, Inc. Common Stock's NASDAQ-traded stock include a P/E ratio of -26.13 and a market capitalization of 2.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MBX on the NASDAQ.